221
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro

, &
Pages 183-206 | Published online: 24 Dec 2014

References

  • EtheridgeMLCampbellSAErdmanAGHaynesCLWolfSMMcCulloughJThe big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine20139111422684017
  • HorstkotteEOdoerferKITowards improved therapies using nanopharmaceuticals: recent patents on pharmaceutical nanoformulationsRecent Pat Food Nutr Agric20124322024423013408
  • Fernandez-FernandezAManchandaRMcGoronAJTheranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platformsAppl Biochem Biotechnol20111657–81628165121947761
  • HallJBDobrovolskaiaMAPatriAKSMcNeilSECharacterization of nanoparticles for therapeuticsNanomedicine20072678980318095846
  • KatebBChiuKBlackKLNanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Neuroimage201154suppl 1S106S12420149882
  • BenezraMPenate-MedinaOZanzonicoPBMultimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomaJ Clin Invest201112172768278021670497
  • LibuttiSKPaciottiGFByrnesAAPhase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineClin Cancer Res201016246139614920876255
  • DemoyMAndreuxJPWeingartenCGouritinBGuillouxVCouvreurPSpleen capture of nanoparticles: influence of animal species and surface characteristicsPharm Res199916137419950276
  • ChoWSChoMJeongJAcute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticlesToxicol Appl Pharmacol20092361162419162059
  • De JongWHHagensWHKrystekPBurgerMCSipsAJAMGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
  • HirnSSemmler-BehnkeMSchlehCParticle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEur J Pharm Biopharm201177340741621195759
  • VirellaGDiagnostic evaluation of phagocytic functionVirellaGImmunology Series58New YorkMarcel Dekker1993311327
  • CampbellPAVanonoBPDrevetsDAMeasurement of bacterial ingestion and killing by macrophagesCollganJEKruisbeckAMMarguliesDHShevachEMStroberWCurrent Protocols in ImmunologyNew YorkJohn Wiley & Sons, Inc199414.6.114.6.13
  • SkoczenSLPotterTMDobrovolskaiaMAIn vitro analysis of nanoparticle uptake by macrophages using chemiluminescenceMcNeilSECharacterization of Nanoparticles Intended for Drug DeliveryNew YorkSpringer Science2011255261
  • Braydich-StolleLKSpeshockJLCastleASmithMMurdockRCHussainSMNanosized aluminum altered immune functionACS Nano2010473661367020593840
  • ShvedovaAAFabisiakJPKisinERSequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivityAm J Respir Cell Mol Biol200838557959018096873
  • MitchellLALauerFTBurchielSWMcDonaldJDMechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in miceNat Nanotechnol20094745145619581899
  • ZogovicNSNikolicNSVranjes-DjuricSDOpposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60)Biomaterials200930366940694619781768
  • MoonEYYiGHKangJSLimJSKimHMPyoSAn increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticlesJ Immunotoxicol201181566721288165
  • Guidance for Industry. S8 Immunotoxicity Studies for Human Pharmaceuticals2006 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm074965.pdf
  • BancosSWeaverJLKatherine TynerKMEvaluation of viability and proliferation profiles of macrophage-treated silica nanoparticles in vitro via plate based, flow cytometry and Coulter counter assaysISRN Nanotechnol20122012 Article ID 454072:11
  • KeeneAMTynerKMAnalytical characterization of gold nanoparticle primary particles, aggregates, agglomerates, and agglomerated aggregatesJ Nanopart Res20111334653481
  • KeeneAMPetersDRouseRStewartSRosenETTynerKMTissue and cellular distribution of gold nanoparticles varies based on aggregation/agglomeration statusNanomedicine20127219920922339133
  • National Research CouncilGuide for the Care and Use of Laboratory AnimalsWashington, DC, USANational Academy Press1996
  • ThakorASLuongRPaulmuruganRThe fate and toxicity of Raman-active silica-gold nanoparticles in miceSci Transl Med201137979ra33
  • GoelRShahNVisariaRPaciottiGFBischofJCBiodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model systemNanomedicine20094440141019505243
  • MukherjeePAntiangiogenic properties of gold nanoparticlesClin Cancer Res2005113530353415867256
  • WarheitDBHow meaningful are the results of nanotoxicity studies in the absence of adequate material characterizationToxicol Sci2008101218318518300382
  • OberdorsterGSafety assessment for nanotechnology and nanomedicine: concepts of nanotoxicologyJ Intern Med200926718910520059646
  • TeeguardenJGHinderliterPMOrrGThrallBDPoundsJGParticokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessmentsToxicol Sci200695230031217098817
  • UlevitchRJTobiasPSReceptor dependent mechanism of cell stimulation by bacterial endotoxinAnnu Rev Immunol1995134374577542010
  • LichtmanSNWangJLemastersJJLPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cellsAm J Physiol19982751G39G469655682
  • NeteaMGKullbergBJvan der MeerJWLipopolysaccharide-induced production of tumor necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD-14-dependent and CD-14-independent pathwaysImmunology19989433403439767415
  • JianZJYangZMillerMSCarterCDSlausonDOBochslerPNInterleukin-6 secretion by bacterial lipopolysaccharide-stimulated bovine alveolar macrophages in vitroVet Immunol Immunopathol1995491–251608588344
  • ZhangQHitchinsVMSchrandAMHussainSMGoeringPUptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediatorsNanotoxicology20115328429520849214
  • KusakaTNakayamaMNakamuraKIshimiyaMFurusawaEOgasawaraKEffect of silica particle size on macrophage inflammatory responsesPLoS One201493e9263424681489
  • GosensIPostJAde la FonteyneLJJImpact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammationPart Fibre Toxicol201073711120180970
  • LeeJYParkWYiDKImmunostimulatory effects of gold nanorod and silica-coated gold nanorod on RAW 264.7 mouse macrophagesToxicol Lett20122091515722155353
  • KimSOhWKJeongYSCytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cellsBiomaterials201132922342250
  • KimJSAdamcakova-DoddAO’ShaughnessyPTGrassianVHThornePSEffects of copper nanoparticle exposure on host defense in a murine pulmonary infection modelPart Fibre Toxicol20118294321943386
  • DeicherRXiaiFCohenGMullnerMHorlWHHigh-dose parenteral iron sucrose depresses neutrophil intracellular killing capacityKidney Int20036472873612846772
  • DanikasKKKarakantzaMTheodorousGLSakellaropoulosGCGogosCAPrognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expressionClin Exp Immunol20081541879718727624
  • PrietoJSubiraMLVastillaACiveiraMPSerranoMMonocyte disorder causing cellular immunodeficiency: a family studyClin Exp Immunol1990791162302828
  • WolachBGavrieliRRoosDBerger-AchituvSLessons learned from phagocytic function studies in a large cohort of patients with recurrent infectionsJ Clin Immunol201232345446622207252
  • SharbaughRJEffect of cyclophosphamide on in vitro phagocytosis of staphylococcus aureusJ Infect Dis197613466196231003015
  • CoraschiDConstantinoLItalianiPInteraction of nanoparticles with immunocompetent cells: nanosafety considerationsNanomedicine201271212113122191781
  • QuGZhangCYuanLQuantum dots impair macrophagic morphology and the ability of phagocytosis by inhibiting the Rho-associated kinase signalingNanoscale201242239224422395807
  • RenwickLCBrownDClouterADonaldsonKIncreased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle typesOccup Environ Med200461544244715090666
  • LiuHYangDYangHComparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: silver, zinc oxide and titanium dioxideJ Hazard Mater2013248–249478486
  • KodaliVLittkeMHTiltonSCDysregulation of macrophage activation profiles by engineered nanoparticlesACS Nano2013786997701023808590